Evaluating Whether Treating Elevated Blood Pressure in the Inpatient Setting Impacts Patient Outcomes

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorElizabeth Pfoh

About this trial

The vast majority of the 36.2 million individuals admitted to U.S. hospitals are diagnosed with hypertension and experience an elevated blood pressure (BP) reading during hospitalization. There are no guidelines for managing asymptomatically elevated BPs in the inpatient setting, and growing observational evidence suggests that antihypertensive medication intensification increases harm. The proposed study tests whether a unit-based intervention (ACT-BP) can reduce antihypertensive medication intensification and provides information that is scientifically necessary for designing a cluster-randomized clinical trial that identifies the impact of intensification after experiencing an asymptomatically elevated BP on patient outcomes.

Eligibility criteria

Qualifiers

At the unit level: Medical units that do not typically care for patients requiring step-down care.

Disqualifiers

Patients less than 18

Patients experiencing hypertensive emergencies or cardiac symptoms

Patients with active cardiovascular events, such as

Stroke

Trial design

Treatments tested in this trial

  • ACT-BP Intervention

Treatment groups

4 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Elizabeth Pfoh

Lead sponsor

The Cleveland Clinic

Sponsor institution

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator